Atlas Trials

Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma

Clinical trial NCT07686575 · RECRUITING

Trial details

NCT number
NCT07686575
Sponsor
Zhujiang Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
HNSCCOSCCOPSCCIvonescimab
Start date
2026-01-26
Primary completion
2026-08-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.